# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.zacks.com/stock/news/2322717/aptevo-therapeutics-apvo-upgraded-to-buy-heres-what-you-should-know
Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(1.67) per share which beat the analyst consensus estimate of $...